» Articles » PMID: 32862361

Understanding the Enzymatic Inhibition of Intestinal Alkaline Phosphatase by Aminophenazone-derived Aryl Thioureas with Aided Computational Molecular Dynamics Simulations: Synthesis, Characterization, SAR and Kinetic Profiling

Overview
Journal Mol Divers
Date 2020 Aug 31
PMID 32862361
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

The work presented in this paper aims toward the synthesis of aryl thiourea derivatives 4a-l of pyrazole based nonsteroidal anti-inflammatory drug named 4-aminophenazone, as potential inhibitors of intestinal alkaline phosphatase enzyme. The screening of synthesized target compounds 4a-l for unraveling the anti-inflammatory potential against calf intestinal alkaline phosphatase gives rise to lead member 4c possessing IC value 0.420 ± 0.012 µM, many folds better than reference standard used (KHPO IC = 2.8 ± 0.06 µM and L-phenylalanine IC = 100 ± 3.1 µM). SAR for unfolding the active site binding pocket interaction along with the mode of enzyme inhibition based on kinetic studies is carried out which showed non-competitive binding mode. The enzyme inhibition studies were further supplemented by molecular dynamic simulations for predicting the protein behavior against active inhibitors 4c and 4g during docking analysis. The preliminary toxicity of the synthesized compounds was determined by using brine shrimp assay. This work also includes detailed biochemical analysis along with RO5 parameters for all the newly synthesized drug derivatives 4a-l.

Citing Articles

In Silico Prediction of Alkaline Phosphatase Interaction with the Natural Inhibitory 5-Azaindoles Guitarrin C and D.

Seitkalieva A, Noskova Y, Isaeva M, Guzii A, Makarieva T, Fedorov S Molecules. 2024; 29(23).

PMID: 39683860 PMC: 11643677. DOI: 10.3390/molecules29235701.


Ectonucleotidase inhibitors: targeting signaling pathways for therapeutic advancement-an in-depth review.

Sharafat R, Saeed A Purinergic Signal. 2024; .

PMID: 38958821 DOI: 10.1007/s11302-024-10031-0.


Current status of -, -, -heterocycles as potential alkaline phosphatase inhibitors: a medicinal chemistry overview.

Jassas R, Naeem N, Sadiq A, Mehmood R, Alenazi N, Al-Rooqi M RSC Adv. 2023; 13(24):16413-16452.

PMID: 37274413 PMC: 10233329. DOI: 10.1039/d3ra01888a.


2-Benzylidenebenzofuran-3(2)-ones as a new class of alkaline phosphatase inhibitors: synthesis, SAR analysis, enzyme inhibitory kinetics and computational studies.

Ashraf J, Mughal E, Alsantali R, Sadiq A, Jassas R, Naeem N RSC Adv. 2022; 11(56):35077-35092.

PMID: 35493176 PMC: 9042899. DOI: 10.1039/d1ra07379f.

References
1.
Lalles J . Intestinal alkaline phosphatase: multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr Rev. 2010; 68(6):323-32. DOI: 10.1111/j.1753-4887.2010.00292.x. View

2.
Lalles J . Intestinal alkaline phosphatase: novel functions and protective effects. Nutr Rev. 2014; 72(2):82-94. DOI: 10.1111/nure.12082. View

3.
Belli S, Sali A, Goding J . Divalent cations stabilize the conformation of plasma cell membrane glycoprotein PC-1 (alkaline phosphodiesterase I). Biochem J. 1994; 304 ( Pt 1):75-80. PMC: 1137454. DOI: 10.1042/bj3040075. View

4.
Fleisch H, BISAZ S . Mechanism of calcification: inhibitory role of pyrophosphate. Nature. 1962; 195:911. DOI: 10.1038/195911a0. View

5.
Millan J . The role of phosphatases in the initiation of skeletal mineralization. Calcif Tissue Int. 2012; 93(4):299-306. PMC: 3594124. DOI: 10.1007/s00223-012-9672-8. View